Showing 1 - 3 results of 3 for search 'Rammohan Reddy Mogulla', query time: 0.02s
Refine Results
-
1
A multi-centre, single arm, Phase 3 study to assess the safety and reactogenicity of biological Es Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine in ≥6 months old infa... by Subhash Thuluva, Ramesh V. Matur, Subbareddy Gunneri, Vijay Yerroju, Rammohan Reddy Mogulla, Chirag Dhar, Raju Esanakarra, Savita Verma, Manish Narang, Madhukar Pandey
Published 2025-08-01Get full text
Article -
2
Immunogenicity and safety of a multi-human dose formulation of Biological E’s 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14®) administered to 6–8-week-old h... by Subhash Thuluva, Ramesh V. Matur, Subbareddy Gunneri, Rammohan Reddy Mogulla, Kamal Thammireddy, Kalyan Kumar Peta, Piyush Paliwal, Niranjana S. Mahantshetti, Ramesh Kumar Banala, Prashanth Siddaiah
Published 2025-04-01Get full text
Article -
3
Safety and immunogenicity of booster doses of an XBB.1.5 RBD subunit COVID-19 vaccine among individuals aged 5–80 years in India: a phase 3, single-blind, randomised controlled tri... by Subhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, Rammohan Reddy Mogulla, Vijay Yerroju, Chirag Dhar, Siddalingaiah Ningaiah, Mallikarjuna Panchakshari, Chandrashekhar S. Gillurkar, Manish Narang, Shivnitwar Sachin Kisan, A. Venkateshwar Rao
Published 2025-09-01Get full text
Article